O. Anoshenkova

The first experience of using upadacitinib in the treatment of rheumatoid arthritis in real clinical practice (results of the multicenter project “RACURS”)

A. Baranov, V. N. Amirjanova, A. Karateev, 2021, Rheumatology Science and Practice.

The ten-year probability of fractures with the FRAX tool: which threshold for intervention to be used and how?

O. Anoshenkova, M. Myagkova, O. Lesnyak, 2019, Rheumatology Science and Practice.

ANALYSIS OF THE RESULTS OF TOFACITINIB THERAPY IN REAL CLINICAL PRACTICE ACCORDING TO THE ALL-RUSSIAN ARTHRITIS REGISTRY (OREL)

A. Baranov, V. Mazurov, R. Samigullina, 2020, Rheumatology Science and Practice.

Are the goals of therapy achievable in patients with rheumatoid arthritis receiving upadacitinib in real clinical practice?

A. Baranov, V. N. Amirjanova, A. Karateev, 2022, Rheumatology Science and Practice.

Ways to improve the diagnosis and treatment of interstitial lung disease associated with systemic sclerosis in the Siberian Federal District (materials of the advisory board of rheumatologists and pulmonologists from December 08, 2019)

L. M. Kudelya, O. Anoshenkova, D. Orlov, 2020 .

Comparison of the effectiveness of different approaches to osteoporosis diagnosis organizing and identification of patients at high fracture risk in the Russian population

O. Anoshenkova, I. Kryukova, M. Myagkova, 2021, Profilakticheskaya meditsina.

PREVALENCE AND RISK FACTORS OF LOW-ENERGY SKELETAL FRACTURES IN PATIENTS WITH CHRONIC INFLAMMATORY DISEASES. THE RESULTS OF A MULTICENTER STUDY OF THE RUSSIAN ASSOCIATION ON OSTEOPOROSIS GLUKOST

L. N. Eliseeva, O. Anoshenkova, E. Belyaeva, 2014 .

Results of a non-interventional multicenter study of management of patients with non-radiological axial spondyloarthritis in real-life clinical practice in the Russian Federation (NiSpAR)

O. Anoshenkova, A. Lila, O. Nesmeyanova, 2024, Modern Rheumatology Journal.